Evidence-based Use of Sugammadex in Children

Start Course Now

Class A Credits: 1

Pharmacology Credits: 0.5

Format: Video

Run time: 47 mins

Course Launch Date: 11/1/19

Course Expires: 2/25/22

Increase your knowledge and confidence related to the use of sugammadex in children.


Post-Test Attempt Notice
A minimum passing score of 80% is required to pass this course. You have TWO opportunities to achieve a passing score. If you fail to achieve a passing score of 80%, you will not receive CE credit for this course.

Content Disclaimer:

The views, information, or opinions expressed within the videos and audio are solely those of the individuals involved and do not necessarily represent those of the American Association of Nurse Anesthetists.

Course content has been prepared by the presenter/developer, and each viewer agrees that the presenter/developer is solely responsible for the content and the accuracy thereof. The viewer agrees that the American Association of Nurse Anesthetists has no responsibility or liability for the accuracy or completeness of the content.

  • Recall the pharmacokinetics of steroidal neuromuscular blocking (NMB) agents and NMB antagonists in children.
  • Describe the risks, benefits, and contraindications of sugammadex specifically related to children and special pediatric population groups.
  • The CRNA will identify two regulatory requirements necessary for medical devices.

Lisa Herbinger, DNP, CRNA

Associate Chair, Samford Nurse Anesthesia Samford University, Children’s of Alabama

Dr. Herbinger has 40 years of pediatric critical care experience with 25 of those as a CRNA. She completed MSN at Samuel Merritt and a DNP at UAB with a focus on pediatric airway management. In 2017, Dr. Herbinger’s manuscript entitled, Evidence Based Use of Cuffed Endotracheal Tubes in Children, was published in the Journal of PeriAnesthesia Nursing. I have taught full-time at Samford University for six years but continue to practice one day a week at Children’s of Alabama.


rocket-idle